Michael Nofi
CIK 1705477 · Chief Financial Officer · last filed 2025-11-13
Michael Nofi is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for EWTX, was dated Nov 13, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
12
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EWTX | Chief Financial Officer | — | $34.83 | — | $0 | 1 | 2025-11-13 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Chief Accounting Officer | 0 | $46.99 | $0 | $0 | 11 | 2025-07-02 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-13 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Disp (D) | −30,623 | $0 | EDGAR |
| 2025-01-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +6,929 | $0 | EDGAR |
| 2025-01-07 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −5,033 | -$192.9K | EDGAR |
| 2024-01-08 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +11,872 | -$88.5K | EDGAR |
| 2023-01-10 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −409 | -$10.8K | EDGAR |
| 2023-01-09 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +8,930 | -$21.5K | EDGAR |
| 2022-01-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −414 | -$23.2K | EDGAR |
| 2022-01-11 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Tax (F) | −567 | -$31.8K | EDGAR |
| 2022-01-10 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +5,748 | $0 | EDGAR |